Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Metoprolol succinate extended-release tablets

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 35 USDMF, 16 CEP/COS, 17 EU WC, 18 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

191 FDF Dossiers, 99 FDA Orange Book, 26 Europe, 27 Australia, 39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 30 BASF, 1 CD Formulation, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 12 Ideal Cures, 3 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

68 Coating Systems & Additives, 66 Fillers, Diluents & Binders, 42 Thickeners and Stabilizers, 39 Solubilizers, 39 Controlled & Modified Release, 32 Disintegrants & Superdisintegrants, 30 Granulation, 30 Direct Compression, 24 Lubricants & Glidants, 22 Film Formers & Plasticizers, 19 Topical, 15 Taste Masking, 13 Parenteral, 12 Chewable & Orodispersible Aids, 11 Rheology Modifiers, 11 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

27 US Medicaid Prescriptions, 8 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

9 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents

8 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Moehs Iberica	Spain	Moehs Iberica S.L. Rubi ES	CEP 2004-202 - Rev 07	Metoprolol succinate	2024-02-27	Valid	Chemical		1448
29/11/2025	TAPI Technology & API Services	Israel	TAPI NL B.V. Amsterdam NL	CEP 2005-221 - Rev 07	Metoprolol succinate	2025-10-28	Valid	Chemical		1448

Metoprolol Succinate Extended-release Tablets

Metoprolol succinate extended-release tablets

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers

35 USDMF

16 CEP/COS

17 EU WC

18 NDC API

29 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

191 FDF Dossiers

99 FDA Orange Book

26 Europe

27 Australia

39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Evonik

1 Rochem International Inc

6 SPI Pharma

13 DKSH

5 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

3 Kirsch Pharma

4 ACG Worldwide

7 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

30 BASF

1 CD Formulation

1 Clariant

15 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

12 Ideal Cures

3 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

2 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

21 Roquette

14 Seppic

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons